Global Adam17 Deficiency Preserves Renal Function and Modulates Integrated Pathogenic Responses in Experimental Diabetic Kidney Disease
International Journal of Molecular Sciences · 09.07.2026 · 27 (14) · 6136
DOI: 10.3390/ijms27146136 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 09.07.2026. Verfasst von Marta Riera und 12 weiteren Autor:innen. Beteiligte Einrichtung: Hospital del Mar Research Institute, 08003 Barcelona, Spain. Hauptthemen laut MEDLINE: ADAM17 Protein, Diabetic Nephropathies, Diabetes Mellitus, Experimental, Kidney. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, ISCIII RICORS programs to National Network for Kidney Research RICORS2040.
Abstract (Originalsprache)
Diabetic kidney disease (DKD) progression results from complex interactions between metabolic stress, inflammatory activation, maladaptive intracellular signalling, and fibrotic remodelling. While previous studies demonstrated renoprotective effects of cell-specific Adam17 deletion, the impact of global Adam17 deficiency on the integrated renal response to diabetes remains incompletely understood. Here, we investigated the effects of tamoxifen-induced global Adam17 deletion in a streptozotocin-induced murine model of type 1 diabetes. Renal function, structural injury, inflammatory responses, stress-related signalling pathways, and fibrotic remodelling were comprehensively assessed in diabetic Adam17 knockout and control mice. Despite persistent hyperglycemia and ongoing albuminuria, diabetic Adam17 knockout mice exhibited preservation of glomerular filtration rate together with marked attenuation of diabetes-associated kidney injury. Global Adam17 deletion reduced mesangial expansion and structural damage, limited macrophage infiltration and chemokine expression, and significantly attenuated fibrotic remodelling. At the molecular level, Adam17 deficiency was associated with selective modulation of stress-related signalling pathways, including reduced activation of the PI3K/Akt axis and partial preservation of mitochondrial stress regulators, without evidence of generalized suppression of cellular stress responses. Notably, preservation of renal function occurred despite persistent albuminuria, supporting a partial dissociation between glomerular permeability alterations and progressive renal dysfunction. These findings demonstrate that global Adam17 deletion confers robust protection against diabetes-associated kidney injury through coordinated attenuation of inflammatory, stress-related, and profibrotic pathways. Our results extend previous cell-specific observations and highlight the context-dependent role of Adam17 in DKD progression, supporting the concept that integrated Adam17-related signalling may represent a relevant therapeutic target in diabetic kidney disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hospital del Mar Research Institute, 08003 Barcelona, Spain.
- Nephrology Department, Hospital del Mar, 08003 Barcelona, Spain.
- Nephrology Department, Hospital Universitari Vall D'Hebron, 08035 Barcelona, Spain.
- Department of Pathology, Hospital del Mar, 08003 Barcelona, Spain.
ORCID-Profile: Marta Riera, Claudia Martyn, Jordi Pujol-Brugués, María José Soler, Juan Sebastián Salazar Castañeda, Marta Crespo
Förderung
- Instituto de Salud Carlos III
- ISCIII RICORS programs to National Network for Kidney Research RICORS2040
Zitieren
APA
Riera, M., Martyn, C., Pujol-Brugués, J., Márquez, E., Rodríguez, E., Palau, V., Soler, M. J., Gimeno, J., Castañeda, J. S. S., Pilco, M., Del Risco, J., Crespo, M., & Barrios, C. (2026). Global Adam17 Deficiency Preserves Renal Function and Modulates Integrated Pathogenic Responses in Experimental Diabetic Kidney Disease. International Journal of Molecular Sciences, 27(14), 6136. https://doi.org/10.3390/ijms27146136
Vancouver
Riera M, Martyn C, Pujol-Brugués J, Márquez E, Rodríguez E, Palau V, et al. Global Adam17 Deficiency Preserves Renal Function and Modulates Integrated Pathogenic Responses in Experimental Diabetic Kidney Disease. International Journal of Molecular Sciences. 2026;27(14):6136. doi:10.3390/ijms27146136
BibTeX
@article{Riera2026,
author = {Riera, Marta and Martyn, Claudia and Pujol-Brugués, Jordi and Márquez, Eva and Rodríguez, Eva and Palau, Vanesa and Soler, María José and Gimeno, Javier and Castañeda, Juan Sebastián Salazar and Pilco, Melissa and Del Risco, Jimena and Crespo, Marta and Barrios, Clara},
title = {Global Adam17 Deficiency Preserves Renal Function and Modulates Integrated Pathogenic Responses in Experimental Diabetic Kidney Disease},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {14},
pages = {6136},
doi = {10.3390/ijms27146136}
}
EUVIMED